Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001

Contributed by: PR Newswire

Tags

CESSATECH-partnership

More Like This

Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001

PR Newswire associated0

Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom

PR Newswire associated0

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Curatis will apply for a Biologic License for C-PTBE-01 in the USA - this will significantly increase the duration of market protection in the USA in the event of approval

Curatis on track: submission of orphan drug designation application in the US for lead product candidate

PR Newswire associated0

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Curatis: Sales growth of 30% in distribution - plus significant expansion of patient target group for lead project C-PTBE-01

European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5